Divi's Lab.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE361B01024
  • NSEID: DIVISLAB
  • BSEID: 532488
INR
8,275.00
26.5 (0.32%)
BSENSE

Aug 10

BSE+NSE Vol: 4.56 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Laurus Labs
Sun Pharma.Inds.
Divi's Lab.
Torrent Pharma
Biocon
Cipla
Dr Reddy's Labs
Zydus Lifesci.
Lupin
Mankind Pharma
Aurobindo Pharma
Why is Divis Laboratories Ltd ?
1
High Management Efficiency with a high ROE of 17.24%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
The company has declared Positive results for the last 7 consecutive quarters
  • NET SALES(Q) Highest at Rs 2,831.00 cr
  • PBDIT(Q) Highest at Rs 934.00 cr.
  • PBT LESS OI(Q) Highest at Rs 808.00 cr.
4
Stock is technically in a Bullish range
  • The technical trend has improved from Sideways on 19-May-26 and has generated -1.82% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band and KST
5
High Institutional Holdings at 39.51%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
6
Market Beating performance in long term as well as near term
  • Along with generating 4.76% returns in the last 1 year, the stock has outperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you buy?
  1. Overall Portfolio exposure to Divi's Lab. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Divi's Lab. for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Divi's Lab.
40.0%
0.21
22.83%
Sensex
-1.65%
-0.49
12.94%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.30%
EBIT Growth (5y)
5.01%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.20
Sales to Capital Employed (avg)
0.66
Tax Ratio
23.73%
Dividend Payout Ratio
36.28%
Pledged Shares
0
Institutional Holding
39.58%
ROCE (avg)
26.14%
ROE (avg)
16.32%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
74
Industry P/E
37
Price to Book Value
13.11
EV to EBIT
62.09
EV to EBITDA
54.52
EV to Capital Employed
16.20
EV to Sales
19.26
PEG Ratio
2.52
Dividend Yield
0.36%
ROCE (Latest)
22.30%
ROE (Latest)
15.65%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
Bearish
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
PBDIT(Q)

Highest at Rs 1,255.00 cr.

NET SALES(Q)

Highest at Rs 3,080.00 cr

OPERATING PROFIT TO NET SALES(Q)

Highest at 40.75%

PBT LESS OI(Q)

Highest at Rs 1,116.00 cr.

PAT(Q)

Highest at Rs 902.00 cr.

EPS(Q)

Highest at Rs 34.04

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Divi's Lab.
Operating Profit (PBDIT) - Quarterly
Highest at Rs 1,255.00 cr. and Grown
each quarter in the last five quarters
MOJO Watch
Near term Operating Profit trend is quite positive

Operating Profit (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 1,116.00 cr has Grown at 51.1% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 738.75 Cr
MOJO Watch
Near term PBT trend is very positive

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Highest at Rs 3,080.00 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 40.75%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 1,116.00 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
Highest at Rs 902.00 cr.
in the last five quarters
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 902.00 cr has Grown at 37.5% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 655.83 Cr
MOJO Watch
Near term PAT trend is positive

PAT (Rs Cr)

Earnings per Share (EPS) - Quarterly
Highest at Rs 34.04
in the last five quarters
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (Rs)